We are live on
!
Find out more
AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
1-Year Est. Return
117.01%
This Fund
S&P 500
This Quarter
Est. Return
+52.6%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$188M
(+44%)
Cap. Flow
-$37.2M
Cap. Flow
% of AUM
-6.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pampa Energía
PAM
|
+$9.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$26.5M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$5.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.12% |
| 2 | Technology | 26.25% |
| 3 | Industrials | 10.15% |
| 4 | Miscellaneous | 3.48% |
Similar funds
MFAM
SL
CIM
SFM
SFG
CGI
VFA
AMG
Aviva Holdings's Q4 2019 Portfolio in Review
As of Q4 2019, Aviva Holdings held 6 positions worth $613M, up 44% from $425M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Aviva Holdings withdrew a net $37.2M in Q4 2019, closing 1 position and reducing 1 holding. Its most notable exit was Medicines Co, an estimated $5.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 59% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aviva Holdings added an estimated $9.05M to Pampa Energía.
- Aviva Holdings added most to Pampa Energía in Q4 2019, an estimated $9.05M increase.
- Aviva Holdings's biggest Q4 2019 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $26.5M.
- Aviva Holdings fully exited Medicines Co in Q4 2019, selling an estimated $5.75M.
- Aviva Holdings's ten largest holdings make up 100% of its $613M portfolio in Q4 2019.
- Aviva Holdings opened 0 new positions and closed 1 in Q4 2019.
- Aviva Holdings's portfolio value rose 44% quarter-over-quarter to $613M.
Based on Aviva Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.